Antitrust Watchdog Forces Drug Divestitures
To maintain competition in the generic injectable drug market, the U.S. Federal Trade Commission said Thursday that Hospira Inc. has to sell five drugs to acquire rival drug maker Mayne Pharma...To view the full article, register now.
Already a subscriber? Click here to view full article